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ABSTRACT Ovomucoid messenger RNA (mRNAom ) comprises ^-8% of the total mRNA in the
estrogen-stimulated oviduct. The recombinant plasmid pOM100 contained DNA complemen-
tary to the 3' end of mRNAom . DNA complementary to the 5' end of mRNAom was obtained
from a partially purified preparation of mRNAom by polymerization by reverse transcriptase in
the presence of a restriction fragment primer from pOM100 . The complementary DNA mixture
was amplified by molecular cloning using poly dG/dC tailing to form recombinant bacterial
plasmids . Recombinant plasmids containing ovomucoid DNA sequences were selected by in
situ hybridization to 32P-labeled pOM100 fragments . The longest plasmid containing ovomu-
coid DNA sequences was designated pOM502 . The complete DNA sequence of both pOM100
and pOM502 was determined . The two plasmids appear to contain sequences complementary
to the entire length of mRNAom . The nucleic acid sequence agrees with the known amino acid
sequences for both ovomucoid and its N-terminal signal peptide . Highly homologous se-
quences occur in two regions that coincide with structural domains of the protein . Comparison
of the sequence of mRNAom with that for other eucaryotic mRNAs allowed identification of
possible functional regions in the mRNA molecule .
The synthesis of ovomucoid and ovalbumin is regulated by
steroid hormones in the chick oviduct (16, 26) . The genes that
code for these two proteins offer an attractive model system for
the study of coordinate expression of unlinked genes in a
steroid-hormone target tissue .
We have previously reported that the ovomucoid gene has
a complex structure containing seven intervening sequences (9,
21) . Messenger RNA sequences are required for the study of
the fine structure ofcomplex eucaryotic genes . Previous knowl-
edge of mRNA sequences allowed the identification of the
cleavage points at which splicing of primary transcripts must
occur (6, 8, 19) . Features of eucaryotic mRNA, such as 5'
leader sequences, initiation signals, 3' noncoding regions, and
possible secondary structures have been studied by nucleic acid
sequencing (2, 11, 14, 23) . Comparison of mRNA sequences
from various sources have led to the identification ofconserved
regions which may have structural or functional significance
(2, 20, 27, 29). Sequences of coding regions have elucidated
unknown protein sequences (23) and will allow correlation of
conservation of nucleic acid sequences with protein structural
and functional domains .
To determine the nucleotide sequence of the ovomucoid
structural gene, we have synthesized and cloned DNA comple-
480
mentary to essentially the entire ovomucoid mRNA
(mRNAom ) . The sequence was contained within the plasmids
pOM100, (33) which included the 3' end and pOM502, which
contained the 5' sequence . The entire nucleic acid sequence
corresponding to mRNAom is contained in the present manu-
script and provides an interesting comparison with the amino
acid sequence of ovomucoid (17) . The sequence is also com-
pared with sequences of other eucaryotic mRNAs, particularly
that for ovalbumin, in an effort to identify common primary
and secondary structural features.
MATERIALS AND METHODS
Materials
Restriction enzymesHae 111, Hinc II, Hpa II, EcoRI, Alu 1, Bam HI, and Sau
IIIA were obtained from Bethesda Research Laboratories, Rockville, Md. Re-
striction enzymes Hinf I, Hha 1, Hph 1, Mbo II, Psi 1, Kpn I, andAva 11 were
purchased from New England Biolabs, Inc., Beverly, Mass. S, nuclease was
obtained from Miles Laboratories, Inc ., Elkhart, Ind . Bacterial alkaline phospha-
Ease was purchased from Worthington Biochemical Corp., Freehold, N. l ., and
T4 polynucleotide kinase from Boehringer Mannheim Biochemicals, Indianap-
olis, Ind . AcA34was purchased from LKB Instruments, Inc ., Rockville, Md. [y-
y2P]ATP (3,000 Ci/mmol) was purchased from Amersham Corp., Arlington
Heights, Ill. Hydrazinewas purchased from Pierce Chemical Co ., Rockford, Ill .,
and carbónate-free NaOH from J . T . Baker Chemical Co ., Phillipsburg, N. J .
THE JOURNAL OF CELL BIOLOGY " VOLUME 87
￿
NOVEMBER 1980 480-487
© The Rockefeller University Press " 0021-9525/80/11/0480/08 $1 .00Piperidine (Fisher Scientific, Co ., Pittsburgh, Pa.) was redistilled before use .
Avian myeloblastosis virus reverse transcriptase was supplied by Dr. J . W.
Beard, Life Sciences, Inc ., St . Petersburg, Fla . Calf thymus terminal deoxynu-
cleotidyl transferasewasagenerous gift ofDr .R . Ratliff, University ofCalifornia,
Los Alamos,N . M.
Internally primed cONA synthesis
The recombinant plasmidpOM100 (600 pg; 33)was digested with 400 U Pst
I (I U will digest 1 pg of DNA/h at 37°C) for 15 h at 30°C in 1.5 ml of reaction
volume . The 204 base pair Psi I fragment (33) was isolated by electrophoresis in
a 4.5% polyacrylamide slab gel . The gel was prepared in a total volumeof 150ml
with a 1:20 ratio of NN'-methylenebisacrylamide to acrylamide, 200 pl of
N,N,N',N'-tetramethylethylenediamine, and 0.13 g of ammonium persulfate in
40 mM Tris-acetate, pH 8.0, 18 mM NaCl, I mM EDTA . The fragment was
eluted from a gel slice according to the method of Maxam and Gilbert (22) .
To remove residual polyacrylamide, an 11 .5 x 0.7-cm AcA34 gel filtration
column was prepared in 10 mM Tris-HCI, pH 7.6, 100mM NaCl . The column
was calibrated and equilibrated with transferRNAand undigested recombinant
plasmid DNA . Fractions of 0.6 ml were collected and assayed by analytical
polyacrylamide gel electrophoresis . Fractions containing the204byPst I fragment
were pooled .
The purified fragment (0 .5 ug) was denatured at 100°C for I min and
quickcooled in ice. A 30-fold molar excess of partially purified mRNAom (33)
wasadded in a final reaction volume of250 Al containing 10mM Tris-HCI, pH
7.4, 180mM NaCl,and 2mM EDTA . Thehybridization reaction was terminated
after 1 min at 68°C (R ot = 2.5 x 10 -z) by freezing at -70°C . The primer-
template complexwas precipitated with the nonspecificRNAin the mixture with
2.5 vol of 95% ethanol .
The synthesis ofDNAcomplementary to the 5' end ofmRNA.,n by reverse
transcriptase (242 U/ml)was performed as previously described (36) . Under the
conditions described above, complementaryDNA., (cDNAom) synthesis is oligo
dT independent. Synthesis of double-stranded cDNAom and cleavage of the
terminal hairpin loop were carried out as described previously (33) .
Preparation and Amplification of
Recombinant Plasmids
Psi I cleaved pBR322 (4)was tailed with dG residues and ds cDNAom with
terminal poly (dC) residues in the presence ofterminal transferase undercondi-
tions described previously (33). The two species were mixed in a 1:1 M ratio and
annealed after heating at 70°C in 10 mM Tris, pH 7.4, 100 mM NaCl, I mM
EDTA .
The recombinant plasmid mixture (1 .5 pg/ml) wasmixed with 2 vol ofCaCl 2 -
treated recipient cells (Escherichia cotiK strain RRI; 4) . After incubation on ice
for 60 min, 15-Id aliquots were spread into L-agar plates containing 25 pg/ml
tetracycline (Tc) and incubated at 37°C . Tc-resistant colonies were picked and
transferred to a fresh Tc plate .
Selection of cDNA om-containing Recombinants
Tc-resistant colonies were transferred to a Millipore filter disk (Millipore
Corp ., Bedford, Mass.) and lysed in situ by the method ofGrunstein andHogness
(l3). The filter was hybridized in the presence of"P-labeled pOM 100 Pst 204
(bp) fragment after treatment in Denhardt's solution (5, l0) . Positive colonies
were grown separately, and plasmidDNAwas prepared bya modification ofthe
method ofKatz et al. (18). PlasmidDNAwas incubated with restriction enzymes
Pst I or Hha I and the digestion products were separated on a6% polyacrylamide
slab gel (33) to determine the length ofthe inserted cDNA.
Preparation of End-labeled Fragments
Routinely, 40lAg ofplasmidDNAwasdigested withan appropriate restriction
endonuclease at 1 U/pg DNA for 2-3 h at 37°C in a 200-pl reaction mixture.
After precipitationwith 2.5 vol ofethanol(95%) inthe presenceof0.3MNaOAC,
the dried pellet was resuspended in 40 pl ofH 2Ofor 5' end labeling, or 31 pl of
H 2Ofor 3' end labeling.
For 5' end labeling, concentrated bacterial alkaline phosphatase (10 x BAP)
buffer (5 pl) was added to give a final concentration of70mM Tris, pH 8.3, 10
mM MgCl,, 5 mMDTT . The reaction was initiated by adding 17 .5 U of bacterial
alkaline phosphatase (5 pl) . Incubation was carried out for 30 min at 37°C . The
reaction was stopped by extraction with Tris-saturated phenol . The aqueous
phasewas precipitated three times from 0.3 M NaOAc, pH 5.5, with 2.5 vol of
ethanol at -70°C . The dried pellet was resuspended in 20pl ofkinase buffer (50
mM glycine-NaOH, 10 MM MgC12, 5 mM dithiothreitol, 0.1 mM spermidine,
25% glycerol) andadded to 200 pCi ofdry [y-'P]dATP. T, polynucleotide kinase
(2-4pl) was added, and the reaction incubated at 37°C for 30 min.
Alternatively, labeling of the 3' ends of restriction sites containing single-
stranded 5' termini was accomplished by incubation ofthe digested DNA with
130 tiCi of [a-'2P]deoxy nucleoside 5'-triphosphate and the Klenow fragment of
DNA polymerase I in 50mM Tris-HCI, pH 8.0, 5 MM MgC12, 10 mM mercap-
toethanol, and 50 jag/ml bovine serum albumin for 60 min at 15°C. The
nucleoside triphosphate used contained the base complementary to the first
unpaired base in the restriction site (e .g., dATP when labeling a Hinf I site:
5'GANTC-G-3') . In this way, both strands can be sequenced from a single
restriction site by using both labeling procedures on aliquots of a single digest .
After labeling, a sucrose/dyes solution was added to final concentration of
10% sucrose, 0.05% bromophenol blue, 0.05% xylene cyanole FF . The labeled
products were separated on a 4% neutral polyacrylamide gel . Fragments of
interest were cut and eluted from the gel by the method ofMaxamand Gilbert
(22) .
Separation of Labeled Ends
Two singly labeled fragments for DNA sequencing were generated by incu-
bation with an appropriate restriction enzyme . The two labeled products were
then separated and eluted from a4 or 6% polyacrylamide gel.
Alternatively, the fragment was resuspended in 98% deionized formamide,
heated to 100°C for 3 min and quick cooled. Thecomplementary strands ofthe
fragment were separated by electrophoresis through a20% polyacrylamide/7 M
urea thin gel (28), 200 x 400 x 0.3 mm, with wide slots. Electrophoresis was
carried out from 6 to 16 h, dependingon fragment length, at 48W. Separated
strands were cut and eluted from the gel as described above.
DNA Sequencing
DNA sequencing reactions were performed according to the method of
Maxam and Gilbert (22), with some exceptions . The alternate G and A> C
reactions (22) were used exclusively . Two time points were taken for each
reaction :T+ C, 7 and 15 min ; C, 10 and 20 min; A, 3and 10 min ; and G, 10 and
30 min. /3-Elimination steps for all reactions were carried out in l0% piperídine
at 90°C for 30 min . Final reaction products were resuspended in 98%formamide
containing 0.25% bromophenol blue and 0.25% xylene cyanole FF, boiled for 3
min, chilled, and loaded onto 8 and 20% polyacrylamide/7 M urea thin gels.
Length of each electrophoresis run was determined by fragment length and the
region ofinterest to be sequenced .
RESULTS
Recombinant Plasmids Containing cDNA om
Preparation of the recombinant plasmid pOM100, which
contains cDNA synthesized from mRNAom, was described
previously (33) . This plasmid contained a 650 by DNAom
insert, but lacked -150 by corresponding to the 5' end of
mRNAom . To obtain cDNA sequences containing the 5' end of
the mRNA sequence, we have synthesized and cloned another
cDNA molecule with a fragment of pOM100 as a specific
primer .
Plasmid pOM100 was digested with EndoR Pst I and the
204 by central fragment was purified from an acrylamide gel
slice . The purified fragment was then hybridized with a par-
tially purified preparation ofmRNAom . DNA complementary
to the 5' end ofmRNAom was synthesized by reverse transcrip-
tion in the absence of an oligo dT primer . The use of a
sequence-specific primer prevented the polymerization of
cDNA from mRNAs other than mRNAom . Double stranded
cDNAom was prepared by synthesis with reverse transcriptase,
and the hairpin loop (11) was cleaved with St nuclease . dC
"tails" were added to the 3' ends of S r-treated ds cDNAom by
terminal deoxynucleotidyl transferase so that an average of 16
dCTP residues were added per ds cDNA terminus .
The plasmid vector pBR322 (4) was linearized by cleavage
with Pst I and similarly "tailed" with an average of 11 dGTP
residues per 3' terminus . Chimeric plasmids were formed by
hybridization and an aliquot of the chimeric plasmid mixture
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MaterialsandMethods. All bacterial transfers were carried out
in a certified laminar flow hood in a P-3 physical containment
facility. (These experiments were approved at P-3, EKI con-
tainment in accordance with the Revised Guidelines for Re-
combinant DNA Research, published by the National Insti-
tutesof Health.)
Tc-resistant transformants, of which49 were obtained, were
transferred directly to a nitrocellulose filter and assayed by in
situ hybridization. In this study, 30 of 49 Tc-resistant clones
contained inserted DNA complementary to a [32P]pOM100-
Pst hybridization probe. The 19 clones that did not hybridize
with the pOM100 probe probably represented uncut pBR322.
It has been shown that molecules tailed with dGTP residues
can reanneal in an intramolecular reaction to form stable
monomers (A. Dugaiczyk, personal communication). These 19
clones were not characterized further to distinguish these pos-
sibilities. The recombinant plasmids were screened for insert
size by agarose gel electrophoresis. The largest plasmid, desig-
nated pOM502, was further characterized by restriction map-
ping and Southern blot (30) analysis, as previously described
for pOM100 (33). Fig. 1 shows the positions and extent of the
DNA inserts of plasmids pOM100 and pOM502. Plasmid
pOM502 contains a DNAom insert of 538 nucleotides, excluding
GC tails of 11 by at the 5' end (defined as the 5' end of the
mRNA sequence) and 16 by at the 3' end. Together, the two
plasmids contain 821 nucleotides of cDNAam.
Determination of Nucleotide Sequence
The entire nucleotide sequences of the two cDNAam clones
described above were determined by the chemical modifica-
tionsmethod ofMaxamandGilbert(22).Restriction fragments
used in the sequence determinations are shown diagrammati-
cally in Fig. 2. 11 restriction sites were used as labeling sites.
The variousfragments overlap in several regions, allowing two
independent sequence determinations in many areas. Where
practical, the sequence was also determined from the comple-
mentary strand by 3' end labeling or by judicious selection of
an alternative 5' labeling site. A potential hazard in the design
of sequencing strategy is the presence of small fragments
between closely spaced restriction sites that have been used for
labeling or recutting. Thus, all sites of labeling and recutting
Complementary DNA Clones Derived
from Ovomucoid Messenger RNA
Pst I
￿
Pst I
Pst I
AAAA In)
ENNOW~~~us~~~~~~
.RNA-
cDNA om Sequence Derived from pOM100
®cDNA,,, Sequence Derived from pOM502
- pBR322
"^""" Flomopolymerlc Termini
FIGURE 1 cDNA clones derived from mRNAam. cDNAam was syn-
thesized from mRNAam (top) with a primer fragment from pOM100
(middle) and inserted into plasmid vector pBR322 (see Materials
and Methods) . Plasmid pOM502 (bottom) contained DNA comple-
mentary to the 5' end of mRNA .
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FIGURE 2 Diagram of restriction fragments used in sequencing.
Restriction sites for which positions are shown are only those from
which sequence information wasderived . The number of sites does
not necessarily reflect the total number in the sequence (see Table
I). Arrows indicate the extent of sequence determined from labeling
sites listed at left. Thedirection of the arrow indicates which strand
of thecDNA was sequenced; arrows pointing away from thelabeling
site indicate that the 5' strand was labeled and sequenced, and
arrows pointing toward the labeling site indicate that the 3' strand
was labeled and sequenced. Broken lines indicate portions of the
sequence that were not read in a particular experiment (usually 80-
cm long gels were used to obtain specific regions of the sequence
remote from the labeling site.
were independently sequenced within other restriction frag-
ments to eliminate this possibility.
The sequence of the translated region (54-686) was further
checkedby comparison with the amino acid sequence (17, 34).
The 5' noncoding region was sequenced mainly on one strand
from unambiguous gel patterns. Sequence data from genomic
clones, which have been shown to contain no intervening
sequences in the 5' noncoding region, are in complete agree-
ment with the data from the cDNA clone.
The sequence of the 3' noncoding region was reported by
Buell et al. (7). Our initial data, derived from experiments on
only one strand in the 3' noncoding region, revealed 18 dis-
crepancies with their published sequence. To resolve this dis-
agreement, the sequencesofboth complementary strands were
determined. The data (Fig. 3) clearly show differences in the
sequence of pOM100 and that published by Buell et al. (17).
The number ofdifferences (18) makes it unlikely that all arise
from variations between the two clones.
A computer search (31, 32) of the sequence showed the
positions of all known restriction enzyme recognition sites
(Table I). Table I includes restriction sites throughout the
mRNA sequence, notonly those used in the sequence analysis.
Some sites listed in Table I were determined on the basis of
sequence alone, although most have been shown to occur by
actual cleavage studies as well.
The 5' noncoding region is 53 nucleotides in length. The 5'
terminal nucleotide in the mRNAam sequence as determined
from the cDNA is adenosine. This is consistent with the
capping sites ofothereucaryotic mRNAswhereA oftenfollows
the 7-methyl G cap (20). Because pOM502 wasmade as ashort
reverse transcription product from a cloned primer fragment,
the cDNA product may include sequences complementary to
the 5' terminus of mRNAam. Thelength ofthecomplete cDNA
sequence (821 nucleotides) is in good agreement with theFIGURE 3
￿
Sequence derived from the 3' terminal portion of mRNA._. Thesequencesshown in a, b, and cwere derived from a 169
by fragment of an RI digest of pOM100 recut with Hinc II . Thefragment was 5' end labeled . Thesequencesshown in d and ewere
derived from a 195 by fragment of a Hinf I digest of pOM100 recut with Hha I . This fragment was 3' end labeled . Therefore, all
sequences shown correspond to the anti-mRNA strand . (a) This sequence, derived from a 10% polyacrylamide/7 M urea gel,
corresponds to positions 604-664 in Fig . 4. (b) This sequence, derived from a 10% polyacrylamide/7 M urea gel, corresponds to
positions661-690 in Fig . 4. (c) This sequence, derived from a 20% polyacrylamide/7 M urea gel, corresponds to positions 682-703
in Fig .4 . (d) This sequence, derived from a 20% polyacrylamide/7 M urea gel, corresponds to positions 732 to 778 in Fig .4. (e) This
sequence, derived from a 10% polyacrylamide/7 M urea gel, corresponds to positions 775-821 in Fig . 4, then into the poly A tail
(poly T in this, the antistrand) .
Restriction Endonuclease Recognition Sites in pOM1o0 and
pOM502
TABLE I
Restriction endonuclease recognition sites in pOM100 and pCIM502 . The
positions of recognition sites were determined by computer analysis (31, 32)
of the complete mRNA. , sequence . All positions, except where indicated,
have been detected by actual enzyme cleavage studies as well . The cleavage
site, when within the recognition sequence, is designated by / . The cleavage
point of Bal I is unknown . Y, pyrimidine; R, purine .
* Numbers correspond to the first nucleotide in the recognition sequence
and, therefore, do not necessarily correspond to the cleavage site .
$ Enzymes tested for which no site was present include : Hind III, Hae II, Hha
I, Hga I, Hpa I, EcoRII, Ava I, Bcl I, Bgf II, Taq I, Tac I, Pvu II, Sst II and III,
Sal I, Xho I, and Xba I .
§ These positions were determined from the computer search of the sequence
only.
estimated length ofmRNA._ (33) . Furthermore, another plas-
mid, obtained in these experiments, of similar size to pOM502
was shown to terminate at exactly the same position aspOM502
(data not shown) . This suggests that reverse transcription of
mRNA._ from the internal primer went to completion . How-
ever, we cannot formally exclude the possibility that a few
nucleotides were removed during S t nuclease cleavage of the
covalently closed double-stranded cDNA.
The 5' noncoding sequence is very GC-rich (67.2%) as
compared with the total mRNA sequences (52.0%) or chicken
DNA (43.5%). This segment is particularly low in U. Only 5
U's occur in the 53 nucleotides preceding the AUG initiator
codon.
The initiator AUG is the first AUG triplet in the sequence .
It has been suggested that AUG is the only signal sequence in
the 5' noncoding region of eucaryotic mRNA (2) . Two short
regions of complementarity with the 3' end of 18S rRNA occur
in this region . One, CACC, occurs immediately before the
initiator AUG and is complementary to nucleotides 21-24
from the 18S rRNA 3' end (1). Another sequence, GCAG,
which is complementary to nucleotides 14-17 in 18S rRNA (1),
is repeated four times at quite regular intervals from the
complementary sequence at theAUG . These structural features
may be important in properly positioning mRNA._ on the
ribosome during translation .
Translated Region
Ovomucoid has recently been sequenced (17) and the amino
acid sequence corresponds to the nucleotide sequence from
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Enzyme* Position$ Sequence
Hae III 56, 392, 473 GG/CC
Hinc Il 480, 531 GTY/RAC
Hinf I 226, 421, 653, 728 G/ANTC
Hpa Il 18,37 C/CGG
Hpa I 424, 706, 746 GGTGA or TCACC
Eco RI 702 G/AATTC
Alu I 694, 774, 779 AG/CT
Barn HI 714 G/GATCC
Bal I 55§ TGGCCA
Sau IIIA 715 /GATC
Mbo Il 70, 570 GAAGA or TCTTC
Pst I 29, 137, 332, 536 CTGCA/G
Sst I 773§ GAGCT/C
Kpn I 216 GGTAC/C
Ava Il 197,377 G/G (A/T)CC
Asu I 197, 377, 391,§ 472§ G/GNCCMET ALA MET
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FIGURE 4
￿
Complete sequence of mRNAom . The sequence determined from the recombinant plasmids is presented in the mRNA
"sense" with U's substituted for T's and the amino acid sequence above. *, Amino terminus of the mature protein after secretion;
***, nonsense codon that signals end of translation.
positions 135 to 686. The two sequences agree completely,
lending credence to the accuracy of each.
Ovomucoid is a secreted protein and, like other secretory
proteins, has a hydrophobic signal peptide (3) at its amino
terminus . The sequence of this peptide (34) agrees with the
nucleic acid sequence from 54-125 in Fig. 4. The entire trans-
lated region is 629 nucleotides in length and is terminated by
the nonsense codon, UGA .
Codon usage in eucaryotic mRNAs is nonrandom (11, 14,
23). Table II shows codon usage in mRNAom . There are 11
codons of 61 possibilities (excluding nonsense codons) that are
not represented in mRNAom . Several amino acids are coded by
an especially nonrandom set of synonomous codons, particu-
larly those for Asn and Arg . The only amino acid not repre-
sented at least once is tryptophan. 40% of the codons have C
in the third position. The distribution of C-terminated codons
is identical in both the signal peptide and the mature protein
sequence .
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Codons containing the dinucleotide CpG are particularly
rare, occurring only three times in 211 coding triplets. Without
regard to coding frame, 26 CpG dinucleotides occur in
mRNAom. The dinucleotide UpA occurs only 23 times in
mRNAom , making it the least represented of the 16 possible
dinucleotide combinations. However, it occurs 10 times within
codons.
The amino acid sequence of ovomucoid revealed three struc-
tural domains in the protein (17) . Comparative sequencing
results from several species indicated that domains I and II had
diverged more recently than II and III. Homology between the
amino acid sequences of domains I and II supported this
theory. Table III shows the homology between the nucleotide
sequences that correspond to the three protein domains. The
nucleotide sequences within domains I and 11 (positions 126-
320 and 321-515 in Fig. 4) are homologous. Even greater
homology (85%) exists between the regions 216-263 and 411-
458 within domains I and II . Domains II and III, and I and III3' Noncoding Region
DISCUSSION
TABLE II
Codon Usage in mRNA.,
show less homology, being only slightly above background.
Random homology was established by comparing domain I
sequences with the 3' noncoding region (34%) or with ovalbu-
min mRNA sequences (36%). As might be expected if the
domains represent diverging copies of a primordial sequence,
the homology between nucleic acid sequences is greater than
between amino acid sequences. However, amino acid side
chains, which may be required to maintain protein structure or
function, are more highly conserved (Table III) than the amino
acid sequence itself.
The 3' noncoding region consists of 134 nucleotides beyond
the translation stop signal. The G + C content (50.4%) of this
region is very similar to that of the coding region (51.0%) and
the mRNA as a whole (52.0%).
The 3' noncoding sequence represents 16.3% of the total
length of mRNAom. This length is similar to mRNAs that code
for a-globin (17.4%; 14) and ß-globin (16.5%; 11). However, it
is remarkably shorter than the analogous region in ovalbumin
mRNA, which comprises 34.3% of the ovalbumin mRNA (23).
The sequence in this region is not recognizably different
from that of the translated region. The longest homopolymeric
sequence is U,CUa (795-802). The translated region contains
several N4 sequences and the longest homopolymeric sequence
in mRNAom is G5 (473-477). The hexanucleotide AAUAAA,
which is conserved in eucaryotic mRNAs (27), is present only
once in mRNAom. The position of this conserved sequence at
19 residues from the poly A is similar to its position in other
eucaryotic mRNA molecules (27).
Nucleotide sequences ofeucaryotic messenger RNA have pro-
vided important information regarding mRNAstructure (2, 11,
14, 23) and possible functional sites, such as ribosome binding
sites (20, 29) and the AAUAAA near the 3' end (27). Secondary
structures, functional codons, 5' leader sequences, 3' noncoding
regions, and unknown protein sequences have all been eluci-
dated by mRNAsequences. The evaluation ofprotein function
may be reflected in highly conserved coding sequences. Re-
cently, mRNA sequences have been crucial in defining the fine
TABLE III
Homology between Sequences of Structural Domains of
Ovomucoid
Percent of homology between structural domains of ovomucoid. Sequences
were compared according to the alignment of the structural domains of the
protein by Kato et al. (17). NA, nucleic acid sequence; AA, amino acid
sequence; AA groups, amino acids grouped according to characteristic side
chain: hydrophobic-Phe, Leu, Ile, Met, Val, Pro, Ala, Tyr, Trp; polar-Ser, Thr,
Gin, Asn, Cys, Gly; basic-His, Lys, Arg; acidic-Asp, Glu.
structure ofcomplex eucaryotic genes. Genomic DNA contains
both structural and intervening sequences that cannot be dis-
tinguished without complete mRNA sequences. The splice
points at which RNA processing occurs have been determined
by comparison ofmRNA sequences with native gene sequences
(6, 8, 19). The mRNAom sequence reported here was used as a
guide in identifying sequences flanking the 5' and 3' ends of
the ovomucoid gene (21).
The recombinant plasmid pOM100 (33) contained ^-80% of
the mRNAom sequence, including the 3' end. To obtain a copy
of the 5' end of the mRNAom sequence, we used a restriction
fragment from pOM 100 as a specific primer. The primer was
used to clone the 5' sequence of mRNAom in the presence of
contaminating mRNA species. Cloned complementary DNAs
synthesized from oligo dT primers have been shown not to
contain DNA complementary to the 5' terminus of the mRNA
template (11, 14, 15, 23, 24, 33). In our experience, the longest
cDNAs (examined aftercloning) vary widely in length (24, 33).
Our present findings suggest that it may be possible to tran-
scribe cDNA to the 5' terminus of an mRNA template and
maintain full length during cloning procedures. The two long-
est cDNA inserts obtained in these experiments terminate at
an identical nucleotide position in mRNAom, which may be the
5' terminus. Synthesizing short cDNA products from cloned
internal primers may provide an advantage in obtaining com-
plete cDNA sequences. However, to confirm this point, direct
end labeling and sequencing of mRNAom is required.
The mRNAom sequence can be separated into three seg-
ments, the 5' and 3' noncoding regions and the translated
region. The 5' noncoding region is 53 nucleotides in length.
Ovalbumin mRNAhas a 5' noncoding region of similar length
(23). The AUG codon at the beginning of the translated region
is the only AUG triplet in the 5' noncoding sequence. Whereas
recognition of the first AUG codon during initiation of trans-
lation is a general feature of eucaryotic mRNAs, the distance
between the AUG and the 5' cap varies greatly (20). It has
been suggested that the AUG initiator is the only signal
sequence in the 5' noncoding region of eucaryotic mRNAs (2).
However, some interesting homologies were revealed by com-
paring ovomucoid and ovalbumin mRNAs. There is an 11-
nucleotide sequence surrounding the initiator AUG that is
homologous in these two mRNAs. The sequence UCAC-
CAUGGNC occurs in both molecules where N is the only
nonhomologous nucleotide. This sequence contains the tetra-
nucleotide CACC, which is complementary to the 3' end of
18S rRNA (1). Another homologous region is the tetranucleo-
tide GCAG, which occurs at -33 and -34 from the AUG in
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I/III 40 36 70ovomucoid and ovalbumin mRNAs, respectively . This se-
quence is also complementary to the 3' end ofrRNA (1) . It has
been suggested that these regions, which appear to be conserved
among several eucaryotic mRNAs, mayact to properly position
theAUG initiator on the 40S ribosomal subunit (29), There is
no other apparent homology between ovalbumin and ovomu-
coid mRNA in their 5' noncoding regions.
OvalbuminmRNAmay have a stable hairpin-loop structure
at its 5' end (23, 29) . This structure may serve to reduce the
cap-AUG distance and facilitate ribosome binding or initia-
tion of translation. No such stable structure can be drawn for
the 5' end ofmRNAom . However, it is interesting that GCAG,
which is present in both ovalbumin andmRNAom andhas 18S
rRNA binding potential, is repeated four times in the 5'
noncoding region of mRNAom at regular intervals from the
homologous sequence surrounding theAUG. Thecap-AUG
distance in mRNAom could be reduced by interaction of the 3'
end of 18S rRNA with these regularly repeated sequences .
The internal homology in the translated region reflects the
known protein structure of ovomucoid . Three homologous
domains were identified from the amino acid sequence . The
higher level of homology seen in the nucleotide sequence
supports the gene duplication theory of Kato et al . (17) . The
very strong homology between two regions of domains I and
11 (216-263 and 411-458) may be indicative of a functional
role for the amino acidscoded in these regions . This possibility
is difficult to assess because the in vivo function ofovomucoid
is unknown . The active site for in vitro trypsin inhibition by
ovomucoid lies in domain I outsidethehighly conservedregion
(17) .
The use of synonomous codons in the translated region is
nonrandom . Selective use of isoaccepting tRNA may provide
abasis for developmental control of some proteins . This mech-
anism appears not to occur in the oviduct, as ovomucoid and
ovalbumin are coordinately expressed but have different isoac-
cepting tRNA requirements . ThemRNAom translated sequence
is rich in C-terminated codons. 40% of the 211 triplets end in
C. Pyrimidine-terminated codons are favored over purine-ter-
minated codons 66-34% . Of the four nonviral eucaryotic
mRNAs sequenced thus far, those for a-globin (14) and ovo-
mucoid strongly favor pyrimidine-terminated codons (64 and
66%, respectively), and iß-globin (11) and ovalbumin (23) are
relatively neutral in this respect (56 and 53%, respectively) .
Among the pyrimidine-restricted codons (12), those ending
in C predominate (63%) in mRNAom as well. Fitch (12) sug-
gested that preferential use ofC in the third position of codons
selects fornonwobblebase pairing during translation, resulting
in alower error rate. At the active site for trypsin inhibition by
ovomucoid, three pyrimidine-restricted codons occur, all of
which end in C. In the highly conserved regions of protein
domains I and Il discussed above, C-terminated codons pre-
dominate amongthe pyrimidine-restricted codons, but they are
not used exclusively . In the absence of a well-characterized in
vivo function for the protein, it is difficult to assess the impor-
tance of this phenomenon to the maintenance ofprotein func-
tion .
Codons containing the dinucleotide CpG are particularly
rare . Only three of 211 triplets contain CpG. If themRNA is
taken as a whole without regard to reading frame, 26 CpG
dinucleotides occur . This is significantly below the 51 expected
by chance in a random 821 nucleotide sequence . Other eucar-
yotic mRNAs (11, 14, 23) have been shown to contain few
CpG dinucleotides. The reason for this is unknown but it has
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been suggested that methylation of cytosine residues at CpG
makes this a hot spot for mutation, causing low CpG levels
(14, 25) .
The sequences presented here have been independently
tested by comparison with amino acid sequences (17, 34) . The
protein and nucleic acids sequences agree completely (M .
Laskowski, personal communication) . Noncoding sequences
were determined from two independent sources, the cDNA
clones pOM502 (5') and pOM100 (3') and the ovomucoid
native gene clones (9, 21) . Throughout the sequence, all restric-
tion sites used for 5' end labeling or secondary cleavage were
determined from overlapping fragments . This precaution al-
lowed us to prove that sequences found on either side of a
labeling or resulting site are contiguous and eliminates the
possibility of missing a small fragment between two closely
spaced restriction sites . Despite theapparent accuracy indicated
by the agreement between the nucleic acid and protein se-
quences and the precautions taken to maintain sequencing
accuracy, we cannot completely exclude the possibility of an
error .
The 3' noncoding region and terminal 75 nucleotides of
coding sequences were sequenced from the unique EcoRI site,
and apparently oneHinf I site, by Buell et al . (7) . Oursequence
of this region, derived from both 5' and 3' labelings of the
EcoRI site and Hinf I sites (positions 653 and 728), differs from
their published sequence at 18 positions (see Fig. 3) . Whereas
an occasional variation between cloned sequences may be
possible, we suspect that the large number of discrepancies in
these sequences is caused by technical differences. We at-
tempted to further validate our sequence by carrying out
determinations on each of the complementary strands.
The mRNAom sequence has been used to identify possible
regulatory sequences that flank the ends of the native gene
(21) . The sequences at the 14 "junctional sequences" within
the ovomucoidgene are currently beingdetermined. It is hoped
that comparison of these sequences with those of ovalbumin
(6, 8) and other eucaryotic genes (19, 35) will lead to the
isolation or direct synthesis of an "average" junctional splicing
site . This oligonucleotide could be used in the assay (as a
substrate) or purification (asan affinity probe) oftheenzyme(s)
responsible for eucaryotic mRNA splicing .
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